These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. DIAgnosis and Management Of familial hypercholesterolemia in a Nationwide Design (DIAMOND-FH): Prevalence in Switzerland, clinical characteristics and the diagnostic value of clinical scores. Miserez AR; Martin FJ; Spirk D Atherosclerosis; 2018 Oct; 277():282-288. PubMed ID: 30270060 [TBL] [Abstract][Full Text] [Related]
47. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece. Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044 [TBL] [Abstract][Full Text] [Related]
48. Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study. Pirillo A; Garlaschelli K; Arca M; Averna M; Bertolini S; Calandra S; Tarugi P; Catapano AL; Atheroscler Suppl; 2017 Oct; 29():17-24. PubMed ID: 28965616 [TBL] [Abstract][Full Text] [Related]
49. Effect of mutations in LDLR and PCSK9 genes on phenotypic variability in Tunisian familial hypercholesterolemia patients. Slimani A; Jelassi A; Jguirim I; Najah M; Rebhi L; Omezzine A; Maatouk F; Hamda KB; Kacem M; Rabès JP; Abifadel M; Boileau C; Rouis M; Slimane MN; Varret M Atherosclerosis; 2012 May; 222(1):158-66. PubMed ID: 22417841 [TBL] [Abstract][Full Text] [Related]
50. Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry. Schmidt N; Dressel A; Grammer TB; Gouni-Berthold I; Julius U; Kassner U; Klose G; König C; Koenig W; Otte B; Parhofer KG; Reinhard W; Schatz U; Schunkert H; Steinhagen-Thiessen E; Vogt A; Laufs U; März W Atherosclerosis; 2018 Oct; 277():314-322. PubMed ID: 30270065 [TBL] [Abstract][Full Text] [Related]
51. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia. Tada H; Kawashiri MA; Nohara A; Inazu A; Mabuchi H; Yamagishi M Eur Heart J; 2017 May; 38(20):1573-1579. PubMed ID: 28159968 [TBL] [Abstract][Full Text] [Related]
52. Association Between Cholesterol Efflux Capacity and Atherosclerotic Cardiovascular Disease in Patients With Familial Hypercholesterolemia. Ogura M; Hori M; Harada-Shiba M Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):181-8. PubMed ID: 26543100 [TBL] [Abstract][Full Text] [Related]
53. The familial hypercholesterolaemia phenotype: Monogenic familial hypercholesterolaemia, polygenic hypercholesterolaemia and other causes. Mariano C; Alves AC; Medeiros AM; Chora JR; Antunes M; Futema M; Humphries SE; Bourbon M Clin Genet; 2020 Mar; 97(3):457-466. PubMed ID: 31893465 [TBL] [Abstract][Full Text] [Related]
54. [Familial hypercholesterolemia due to a new mutation in the low density lipoprotein receptor gene]. Korneva VA; Bogoslovskaia TIu; Kuznetsova TIu; Mandel'shtam MIu; Vasil'ev VB Klin Med (Mosk); 2014; 92(7):49-53. PubMed ID: 25775905 [TBL] [Abstract][Full Text] [Related]
55. No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the Familial Hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes. Damgaard D; Jensen JM; Larsen ML; Soerensen VR; Jensen HK; Gregersen N; Jensen LG; Faergeman O Atherosclerosis; 2004 Dec; 177(2):415-22. PubMed ID: 15530918 [TBL] [Abstract][Full Text] [Related]
56. Cascade Screening for Familial Hypercholesterolemia in South Africa: The Wits FIND-FH Program. Raal FJ; Bahassi EM; Stevens B; Turner TA; Stein EA Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2747-2755. PubMed ID: 32878475 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study. Casula M; Olmastroni E; Pirillo A; Catapano AL; ; ; ; ; ; Atherosclerosis; 2018 Oct; 277():413-418. PubMed ID: 30270079 [TBL] [Abstract][Full Text] [Related]
59. Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries. Futema M; Shah S; Cooper JA; Li K; Whittall RA; Sharifi M; Goldberg O; Drogari E; Mollaki V; Wiegman A; Defesche J; D'Agostino MN; D'Angelo A; Rubba P; Fortunato G; Waluś-Miarka M; Hegele RA; Aderayo Bamimore M; Durst R; Leitersdorf E; Mulder MT; Roeters van Lennep JE; Sijbrands EJ; Whittaker JC; Talmud PJ; Humphries SE Clin Chem; 2015 Jan; 61(1):231-8. PubMed ID: 25414277 [TBL] [Abstract][Full Text] [Related]
60. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction. Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]